# Ciprofloxacin

NDC: 51655-216
Generic name: Ciprofloxacin Hydrochloride
Labeler / Manufacturer: Northwind Health Company, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20230317
Marketing ended: 20270228
FDA application: ANDA077859

## Active ingredients

- CIPROFLOXACIN HYDROCHLORIDE: 500 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"51655-216"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=51655-216
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f80ab01d-2533-1b4c-e053-6294a90a6e6a